It is critical for the final piece of the puzzle—experimental evidence for the mechanism of how PPARγ ligands block Ser273 phosphorylation—to be robustly investigated in order to inform future drug design efforts to lower the incidence of T2DM. Here, PPARG is linked to type 2 diabetes mellitus.